切换至 "中华医学电子期刊资源库"

中华口腔医学研究杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 376 -380. doi: 10.3877/cma.j.issn.1674-1366.2023.05.010

综述

白藜芦醇治疗牙周炎和糖尿病的新进展
叶弘, 吕婧喆, 钟良军()   
  1. 杭州师范大学附属医院,杭州师范大学,杭州 310000
  • 收稿日期:2023-06-07 出版日期:2023-10-01
  • 通信作者: 钟良军

New study progress of resveratrol in the treatment of periodontitis and diabetes

Hong Ye, Jingzhe Lyu, Liangjun Zhong()   

  1. Hangzhou Normal University Affiliated Hospital, Hangzhou Normal University, Hangzhou 310000, China
  • Received:2023-06-07 Published:2023-10-01
  • Corresponding author: Liangjun Zhong
  • Supported by:
    National Natural Science Foundation of China(81570989); Hangzhou Health Science and Technology Plan Project(Z20200046); Hangzhou Normal University Graduate Research Innovation Promotion Project(2022HSDYJSKY078)
引用本文:

叶弘, 吕婧喆, 钟良军. 白藜芦醇治疗牙周炎和糖尿病的新进展[J/OL]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 376-380.

Hong Ye, Jingzhe Lyu, Liangjun Zhong. New study progress of resveratrol in the treatment of periodontitis and diabetes[J/OL]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(05): 376-380.

牙周炎和糖尿病是临床上常见的疾病,对患者的健康及生活产生巨大影响。近年来学者研究证实这两种疾病具有很强相关性,因此治疗牙周炎和糖尿病的药物也成为研究热点。白藜芦醇是一种来自于天然植物的多酚类化合物,具有抗炎、抗氧化、降低血脂和调节代谢等作用,同时白藜芦醇不良反应少,获取途径广泛,价格低廉,是一种在牙周炎和糖尿病治疗中应用潜力巨大的辅助药物,也是解决关于慢性炎症性疾病中细菌耐药性问题的一个新思路。本文综述了近年来白藜芦醇应用于牙周炎及糖尿病治疗中的新进展,为进一步研究与应用提供新的思路。

Periodontitis and diabetes are common diseases in clinic, which have a huge impact on the health and life of patients. In recent years, it was proven that these two diseases have a strong correlation, so drugs for treating periodontitis and diabetes have also become a research hotspot. Resveratrol is a kind of polyphenol compound from natural plants, which has anti-inflammatory, antioxidant, lipid lowering and metabolic regulating effects. At the same time, it also has the advantages of small toxic side effects, wide access, low price, etc. It is a kind of auxiliary antibacterial drug with great potential in the treatment of periodontitis and diabetes, and also a new way to solve the problem of bacterial resistance in chronic inflammatory diseases. This article reviewed the new progress of resveratrol in the treatment of periodontitis and diabetes in recent years, in order to provide new ideas for its further research and application.

[1]
John VAlqallaf Hde Bedout T. Periodontal disease and systemic diseases:An update for the clinician[J]. J Indiana Dent Assoc201695(1):16-23.
[2]
Genco RJGraziani FHasturk H. Effects of periodontal disease on glycemic control,complications,and incidence of diabetes mellitus[J]. Periodontol 200020203(1):59-65. DOI:10.1111/prd.12271.
[3]
Stöhr JBarbaresko JNeuenschwander M,et al. Bidirectional association between periodontal disease and diabetes mellitus:A systematic review and meta-analysis of cohort studies[J]. Sci Rep202111(1):13686-13686. DOI:10.1038/s41598-021-93062-6.
[4]
Weiskirchen SWeiskirchen R. Resveratrol:How much wine do you have to drink to stay healthy?[J]. Adv Nutr20167(4):706-718. DOI:10.3945/an.115.011627.
[5]
Bunte KHensel ABeikler T. Polyphenols in the prevention and treatment of periodontal disease:A systematic review of in vivoex vivo and in vitro studies[J]. Fitoterapia2019132:30-39. DOI:10.1016/j.fitote.2018.11.012.
[6]
Chin YTCheng GYShih YJ,et al. Therapeutic applications of resveratrol and its derivatives on periodontitis[J]. Ann N Y Acad Sci20171403(1):101-108. DOI:10.1111/nyas.13433.
[7]
Zhang QXu SXu W,et al. Resveratrol decreases local inflammatory markers and systemic endotoxin in patients with aggressive periodontitis[J]. Medicine(Baltimore)2022101(25):e29393. DOI:10.1097/MD.0000000000029393.
[8]
Raimundo AFFélix FAndrade R,et al. Combined effect of interventions with pure or enriched mixtures of(poly)phenols and anti-diabetic medication in type 2 diabetes management:A meta-analysis of randomized controlled human trials[J]. Eur J Nutr202059(4):1329-1343. DOI:10.1007/s00394-020-02189-1.
[9]
陈小林,张子龙,高天慧,等.白藜芦醇药理作用及机制研究进展[J].中国野生植物资源202241(12):67-76. DOI:10.3969/j.issn.1006-9690.2022.12.013.
[10]
Huang HLiao DZhou G,et al. Antiviral activities of resveratrol against rotavirus in vitro and in vivo[J]. Phytomedicine202077:153230. DOI:10.1016/j.phymed.2020.153230.
[11]
Vestergaard MIngmer H. Antibacterial and antifungal properties of resveratrol[J]. Int J Antimicrob Agents201953(6):716-723. DOI:10.1016/j.ijantimicag.2019.02.015.
[12]
Abedini EKhodadadi EZeinalzadeh E,et al. A comprehensive study on the antimicrobial properties of resveratrol as an alternative therapy[J]. Evid Based Complement Alternat Med2021:8866311. DOI:10.1155/2021/8866311.
[13]
Ben Lagha AAndrian EGrenier D. Resveratrol attenuates the pathogenic and inflammatory properties of Porphyromonas gingivalis[J]. Mol Oral Microbiol201934(3):118-130. DOI:10.1111/omi.12260.
[14]
Kugaji MSKumbar VMPeram MR,et al. Effect of Resveratrol on biofilm formation and virulence factor gene expression of Porphyromonas gingivalis in periodontal disease[J]. APMIS2019127(4):187-195. DOI:10.1111/apm.12930.
[15]
Bahar BSinghrao SK. An evaluation of the molecular mode of action of trans-resveratrol in the Porphyromonas gingivalis lipopolysaccharide challenged neuronal cell model[J]. Mol Biol Rep202148(1):147-156. DOI:10.1007/s11033-020-06024-y.
[16]
Andreou VD′Addario MZohar R,et al. Inhibition of osteogenesis in vitro by a cigarette smoke-associated hydrocarbon combined with Porphyromonas gingivalis lipopolysaccharide:Reversal by resveratrol[J]. J Periodontol200475(7):939-948. DOI:10.1902/jop.2004.75.7.939.
[17]
Li LLi JWang Y,et al. Resveratrol prevents inflammation and oxidative stress response in LPS-induced human gingival fibroblasts by targeting the PI3K/AKT and Wnt/β-catenin signaling pathways[J]. Genet Mol Biol202144(3):e20200349. DOI:10.1590/1678-4685-GMB-2020-0349.
[18]
Casati MZAlgayer CCardoso da Cruz G,et al. Resveratrol decreases periodontal breakdown and modulates local levels of cytokines during periodontitis in rats[J]. J Periodontol201384(10):e58-e64. DOI:10.1902/jop.2013.120746.
[19]
Corrêa MGPires PRRibeiro FV,et al. Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats[J]. PLoS One201813(10):e0204414. DOI:10.1371/journal.pone.0204414.
[20]
Tamaki NCristina Orihuela-Campos RInagaki Y,et al. Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model[J]. Free Radic Biol Med201475:222-229. DOI:10.1016/j.freeradbiomed.2014.07.034.
[21]
Corrêa MGAbsy STenenbaum H,et al. Resveratrol attenuates oxidative stress during experimental periodontitis in rats exposed to cigarette smoke inhalation[J]. J Periodontal Res201954(3):225-232. DOI:10.1111/jre.12622.
[22]
赵燕霞,李迎晓,张硕,等.白藜芦醇联合牙周非手术治疗对2型糖尿病慢性牙周炎患者牙周指标、炎性因子及糖脂代谢的影响[J].中国卫生工程学202120(5):857-860. DOI:10.19937/j.issn.1671-4199.2021.05.061.
[23]
Nikniaz SVaziri FMansouri R. Impact of resveratrol supplementation on clinical parameters and inflammatory markers in patients with chronic periodontitis:a randomized clinical trail[J]. BMC Oral Health202323(1):177. DOI:10.1186/s12903-023-02877-4.
[24]
Bhattarai GPoudel SBKook SH,et al. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis[J]. Acta Biomater201629:398-408. DOI:10.1016/j.actbio.2015.10.031.
[25]
Adhikari NPrasad Aryal YJung JK,et al. Resveratrol enhances bone formation by modulating inflammation in the mouse periodontitis model[J]. J Periodontal Res202156(4):735-745. DOI:10.1111/jre.12870.
[26]
Ikeda EIkeda YWang Y,et al. Resveratrol derivative-rich melinjo seed extract induces healing in a murine model of established periodontitis[J]. J Periodontol201889(5):586-595. DOI:10.1002/JPER.17-0352.
[27]
Matsuda YMinagawa TOkui T,et al. Resveratrol suppresses the alveolar bone resorption induced by artificial trauma from occlusion in mice[J]. Oral Dis201824(3):412-421. DOI:10.1111/odi.12785.
[28]
Wang YJZhao PSui BD,et al. Resveratrol enhances the functionality and improves the regeneration of mesenchymal stem cell aggregates[J]. Exp Mol Med201850(6):1-15. DOI:10.1038/s12276-018-0109-y.
[29]
Walle THsieh FDeLegge MH,et al. High absorption but very low bioavailability of oral resveratrol in humans[J]. Drug Metab Dispos200432(12):1377-1382. DOI:10.1124/dmd.104.000885.
[30]
Lim YRIPreshaw PMLim LP,et al. Pterostilbene complexed with cyclodextrin exerts antimicrobial and anti-inflammatory effects[J]. Sci Rep202010(1):9072. DOI:10.1038/s41598-020-66031-8.
[31]
Ikeda ETanaka DGlogauer M,et al. Healing effects of monomer and dimer resveratrol in a mouse periodontitis model[J]. BMC Oral Health202222(1):460. DOI:10.1186/s12903-022-02499-2.
[32]
Shi JZhang YZhang X,et al. Remodeling immune microenvironment in periodontitis using resveratrol liposomes as an antibiotic-free therapeutic strategy[J]. J Nanobiotechnology202119(1):429. DOI:10.1186/s12951-021-01175-x.
[33]
Tan YFeng JXiao Y,et al. Grafting resveratrol onto mesoporous silica nanoparticles towards efficient sustainable immunoregulation and insulin resistance alleviation for diabetic periodontitis therapy[J]. J Mater Chem B202210(25):4840-4855. DOI:10.1039/d2tb00484d.
[34]
解健,苏俭生.载白藜芦醇及BMP-2同轴纳米纤维膜的构建及其在牙周炎骨缺损重建中应用的实验研究[J].口腔颌面外科杂志201929(6):313-319. DOI:10.3969/j.issn.1005-4979.2019.06.003.
[35]
Lee YHGiraud JDavis RJ,et al. c-Jun N-terminal kinase (JNK)mediates feedback inhibition of the insulin signaling cascade[J]. J Biol Chem2003278(5):2896-2902. DOI:10.1074/jbc.M208359200.
[36]
Darwish MAAbdel-Bakky MSMessiha BAS,et al. Resveratrol mitigates pancreatic TF activation and autophagy-mediated beta cell death via inhibition of CXCL16/ox-LDL pathway:A novel protective mechanism against type 1 diabetes mellitus in mice[J]. Eur J Pharmacol2021901:174059. DOI:10.1016/j.ejphar.2021.174059.
[37]
Costa PPTrevisan GLMacedo GO,et al. Salivary interleukin-6,matrix metalloproteinase-8,and osteoprotegerin in patients with periodontitis and diabetes[J]. J Periodontol201081(3):384-391. DOI:10.1902/jop.2009.090510.
[38]
Takahashi KTakashiba SNagai A,et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease[J]. J Periodontol199465(2):147-153. DOI:10.1902/jop.1994.65.2.147.
[39]
Javid AZHormoznejad RYousefimanesh HA,et al. Impact of resveratrol supplementation on inflammatory,antioxidant,and periodontal markers in type 2 diabetic patients with chronic periodontitis[J]. Diabetes Metab Syndr201913(4):2769-2774. DOI:10.1016/j.dsx.2019.07.042.
[40]
Houstis NRosen EDLander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance[J]. Nature2006440(7086):944-948. DOI:10.1038/nature04634.
[41]
Tsai HCLi YCYoung TH,et al. Citrus polyphenol for oral wound healing in oral ulcers and periodontal diseases[J]. J Formos Med Assoc2016115(2):100-107. DOI:10.1016/j.jfma.2015.01.003.
[42]
Sánchez MCRibeiro-Vidal HEsteban-Fernández A,et al. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model[J]. BMC Complement Altern Med201919(1):145. DOI:10.1186/s12906-019-2533-5.
[43]
Szkudelski TSzkudelska K. Resveratrol and diabetes:From animal to human studies[J]. Biochim Biophys Acta20151852(6):1145-1154. DOI:10.1016/j.bbadis.2014.10.013.
[44]
Cheng PWHo WYSu YT,et al. Resveratrol decreases fructose-induced oxidative stress,mediated by NADPH oxidase via an AMPK-dependent mechanism[J]. Br J Pharmacol2014171(11):2739-2750. DOI:10.1111/bph.12648.
[45]
Etxeberria UArias NBoqué N,et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats[J]. J Nutr Biochem201526(6):651-660. DOI:10.1016/j.jnutbio.2015.01.002.
[46]
Song YZhao MCheng X,et al. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia[J]. J Mol Med(Berl)201795(8):839-849. DOI:10.1007/s00109-017-1534-4.
[47]
马昭杰.中青年2型糖尿病合并高血压患者血脂异常分析[J].中国实用医药202015(8):36-38. DOI:10.14163/j.cnki.11-5547/r.2020.08.014.
[48]
Ma NZhang Y. Effects of resveratrol therapy on glucose metabolism,insulin resistance,inflammation,and renal function in the elderly patients with type 2 diabetes mellitus:A randomized controlled clinical trial protocol[J]. Medicine (Baltimore)2022101(32):e30049. DOI:10.1097/MD.0000000000030049.
[49]
Ebrahim HAAlzamil NMAl-Ani B,et al. Suppression of knee joint osteoarthritis induced secondary to type 2 diabetes mellitus in rats by resveratrol:Role of glycated haemoglobin and hyperlipidaemia and biomarkers of inflammation and oxidative stress[J]. Arch Physiol Biochem2022128(5):1375-1382. DOI:10.1080/13813455.2020.1771378.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[4] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[5] 别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[6] 孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[7] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[8] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[9] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[10] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[11] 杜军霞, 赵小淋, 王浩然, 高志远, 王曼茜, 万楠熙, 张冬, 丁潇楠, 任琴琴, 段颖洁, 汤力, 朱晗玉. 2 型糖尿病的血液透析患者肠道微生物组学高通量测序分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 313-320.
[12] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[13] 李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
[14] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?